lapatinib has been researched along with Alopecia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, O; Fouad, M | 1 |
| Aogi, K; Armour, A; Inoue, K; Iwata, H; Kuroi, K; Masuda, N; Nakayama, T; Nishimura, Y; Rai, Y; Sasaki, Y; Shimizu, S | 1 |
| Ena, L; Ena, P; Fadda, GM; Farris, A; Santeufemia, DA | 1 |
1 review(s) available for lapatinib and Alopecia
| Article | Year |
|---|---|
Risk of mucocutaneous toxicities in patients with solid tumors treated with lapatinib: a systematic review and meta-analysis.
Topics: Alopecia; Antineoplastic Agents; Hand-Foot Syndrome; Humans; Lapatinib; Neoplasms; Pruritus; Quinazolines; Randomized Controlled Trials as Topic; Risk | 2015 |
1 trial(s) available for lapatinib and Alopecia
| Article | Year |
|---|---|
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Diarrhea; Female; Hemoglobins; Humans; Japan; Lapatinib; Middle Aged; Neoplasm Metastasis; Paclitaxel; Quinazolines; Receptor, ErbB-2; Survival Rate | 2015 |
1 other study(ies) available for lapatinib and Alopecia
| Article | Year |
|---|---|
Tufted hair folliculitis in a woman treated with lapatinib for breast cancer.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Folliculitis; Granuloma, Pyogenic; Humans; Lapatinib; Middle Aged; Quinazolines | 2008 |